Spatial trends of breast and prostate cancers in the United States between 2000 and 2005

International Journal of Health Geographics

Volumn 8, Issue 1, 2009, Pages 53-

  Mandal, Rakesh ^a,b   St Hilaire, Sophie ^b   Kie, John G ^b   Derryberry, DeWayne ^b  

^a IDAHO STATE UNIVERSITY   (United States)

^b Nucl Eng Idaho State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; DISEASE INCIDENCE; DISEASE PREVALENCE; HEALTH RISK; PUBLIC HEALTH; REGRESSION ANALYSIS; RISK FACTOR; SPATIAL ANALYSIS;

ARTICLE; BREAST TUMOR; CLUSTER ANALYSIS; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; INCIDENCE; MALE; NATIONAL HEALTH ORGANIZATION; PROSTATE TUMOR; REGISTER; RISK FACTOR; STATISTICS; UNITED STATES;

BREAST NEOPLASMS; CLUSTER ANALYSIS; FEMALE; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; INCIDENCE; MALE; NATIONAL CANCER INSTITUTE (U.S.); PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; UNITED STATES;

NORTH AMERICA; UNITED STATES;

EID: 70449515633     PISSN: None     EISSN: 1476072X     Source Type: Journal    
DOI: 10.1186/1476-072X-8-53     Document Type: Article

References (38)

1. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991, 324(17):1156-1161.
2. United States Cancer Statistics: 2004 Incidence and Mortality. 2007, Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute.
3. National Cancer Institute-State Cancer Profiles. , http://statecancerprofiles.cancer.gov/incidencerates/
4. Lopez-Otin C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998, 19(4):365-396. 10.1210/er.19.4.365, 9715372.
5. Cuzick J. Hormone replacement therapy and the risk of breast cancer. Eur J Cancer 2008, 44(16):2344-2349. 10.1016/j.ejca.2008.07.041, 18783940.
6. Prins GS. Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 2008, 15(3):649-656. 10.1677/ERC-08-0043, 18524946.
7. Osborne M, Boyle P, Lipkin M. Cancer prevention. Lancet 1997, 349(Suppl 2):SII27-30.
8. Diamandis EP, Yu H. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 1997, 24(2):275-282. 10.1016/S0094-0143(05)70373-6, 9126224.
9. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997, 336(20):1401-1408. 10.1056/NEJM199705153362001, 9145676.
10. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 1992, 2(2):132-134. 10.1038/ng1092-132, 1303262.
11. Valeri A, Fournier G, Morin V, Morin JF, Drelon E, Mangin P, Teillac P, Berthon P, Cussenot O. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 2000, 86(6):883-887. 10.1002/(SICI)1097-0215(20000615)86:6<883::AID-IJC20>3.0.CO;2-F, 10842206.
12. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378(6559):789-792. 10.1038/378789a0, 8524414.
13. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992, 70(12):2861-2869. 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G, 1451068.
14. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 1999, 8(5):399-406.
15. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 2006, 6:264. 10.1186/1471-2407-6-264, 1665523, 17096841.
16. John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev 2007, 16(6):1283-1286. 10.1158/1055-9965.EPI-06-1053, 17548698.
17. DeLuca HF. Evolution of our understanding of vitamin D. Nutr Rev 2008, 66(10 Suppl 2):S73-87. 10.1111/j.1753-4887.2008.00105.x, 18844850.
18. U.S. Environmental Protection Agency. , http://www.epa.gov/TRI/guide_docs/pdf/2003/2003_datausepaper.pdf
19. Schwartz GG, Hanchette CL. UV, latitude, and spatial trends in prostate cancer mortality: all sunlight is not the same (United States). Cancer Causes Control 2006, 17(8):1091-1101. 10.1007/s10552-006-0050-6, 16933060.
20. Blot WJ, Fraumeni JF, Stone BJ. Geographic patterns of breast cancer in the United States. J Natl Cancer Inst 1977, 59(5):1407-1411.
21. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 1995, 87(24):1846-1853. 10.1093/jnci/87.24.1846, 7494228.
22. John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 2007, 166(12):1409-1419. 10.1093/aje/kwm259, 17934201.
23. Schwartz GG. Vitamin D and the epidemiology of prostate cancer. Semin Dial 2005, 18(4):276-289. 10.1111/j.1525-139X.2005.18403.x, 16076349.
24. Rhee HJ, de Vries E, Coebergh JW. Does sunlight prevent cancer? A systematic review. Eur J Cancer 2006, 42(14):2222-2232. 10.1016/j.ejca.2006.02.024, 16904314.
25. Giese C, Miethe N, Schlenker G. [Biodegradation of estrogens in stream water]. Berl Munch Tierarztl Wochenschr 2007, 120(3-4):141-147.
26. Sanscartier D, Zeeb B, Koch I, Reimer K. Bioremediation of diesel-contaminated soil by heated and humidified biopile system in cold climates. Cold Regions Science and Technology 2009, 55(1):167-173.
27. Wania F, Westgate JN. On the mechanism of mountain cold-trapping of organic chemicals. Environ Sci Technol 2008, 42(24):9092-9098. 10.1021/es8013198, 19174876.
28. Franz TP, Eisenreich SJ. Snow scavenging of polychlorinated biphenyls and polycyclic aromatic hydrocarbons in Minnesota. Environ Sci Technol 1998, 32(12):1771-1778.
29. Calamari D, Bacci E, Focardi S, Gaggi C, Morosini M, Vighi M. Role of plant biomass in the global environmental partitioning of chlorinated hydrocarbons. Environ Sci Technol 1991, 25:1489-1495.
30. Wania F, Mackay D. Tracking the distribution of persistent organic pollutants. Environ Sci Technol 1996, 30(9):A390-A396.
31. Simonich SL, Hites RA. Global distribution of persistent organochlorine compounds. Science 1995, 269(5232):1851-1854. 10.1126/science.7569923, 7569923.
32. Franz TP, Eisenreich SJ. Snow scavenging of polychlorinated biphenyls and polycyclic aromatic hydrocarbons in Minnesota. Environ Sci Technol 1998, 32(12):1771-1778.
33. Brisken C. Endocrine disruptors and breast cancer. Chimia 2008, 62(5):406-409.
34. Laden F, Hunter DJ. Environmental risk factors and female breast cancer. Annu Rev Public Health 1998, 19:101-123. 10.1146/annurev.publhealth.19.1.101, 9611614.
35. Centers for Disease Control and Prevention, Department of Health and Human Services. , http://www.cdc.gov/DHDSP/library/maps/index.htm
36. Fortin M-J, Mark D. Spatial analysis-a guide for ecologists. 2005, Cambridge University Press.
37. Rangel T, Diniz-Filho JA, Bini LM. Towards an integrated computational tool for spatial analysis in macroecology and biogeography. Global Ecology and Biogeography 2006, 15(4):321-327.
38. United States Department of Agriculture Economic Research Service. , http://www.ers.usda.gov/